Cargando…

Effects of Qianlie Tongqiao Capsule on Bladder Weight and Growth Factors in Bladder Tissue of Rats with Testosterone-Induced Benign Prostatic Hyperplasia

Qianlie Tongqiao Capsule (QTC) is clinically confirmed to be efficacious and safe in treating lower urinary tract syndromes and bladder dysfunction that are induced by benign prostatic hyperplasia (BPH). However, the functional mechanisms of QTC remain unclear. We aim to investigate the effects of Q...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Fan, Zhang, Chun-he, Yan, Jun-feng, Li, Yan-feng, Yang, Yi-jian, Sun, Di
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241338/ https://www.ncbi.nlm.nih.gov/pubmed/30519263 http://dx.doi.org/10.1155/2018/5059267

Ejemplares similares

The Effect of Xialiqi Capsule on Testosterone-Induced Benign Prostatic Hyperplasia in Rats
por: Cai, Hongcai, et al.
Publicado: (2018)

Anti-Inflammatory and Antioxidant Effects of Kelong-Capsule on Testosterone-Induced Benign Prostatic Hyperplasia in Rats
por: Zhang, Ling, et al.
Publicado: (2018)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Benign prostatic hyperplasia and subsequent risk of bladder cancer
por: Kang, D, et al.
Publicado: (2007)

Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction
por: Patel, Nishant D., et al.
Publicado: (2014)

Risk factors for bladder calculi in patients with benign prostatic hyperplasia
por: Huang, Wei, et al.
Publicado: (2017)

Bladder Tissue Microbiome Composition in Patients of Bladder Cancer or Benign Prostatic Hyperplasia and Related Human Beta Defensin Levels
por: Mansour, Bassel, et al.
Publicado: (2022)

Tamsulosin and Solifenacin in the Treatment of Benign Prostatic Hyperplasia in combination with overactive bladder
por: Wang, Hui, et al.
Publicado: (2017)

Inhibitory Effect of Astaxanthin on Testosterone-Induced Benign Prostatic Hyperplasia in Rats
por: Wang, Liping, et al.
Publicado: (2021)

Bladder stone secondary to prostatic urethral lift (PUL) for benign prostatic hyperplasia (BPH)
por: Kang, JiHun
Publicado: (2021)

Qianlie Xiaozheng Decoction Induces Autophagy in Human Prostate Cancer Cells via Inhibition of the Akt/mTOR Pathway
por: Xu, Yuehua, et al.
Publicado: (2018)

Berberine ameliorates testosterone-induced benign prostate hyperplasia in rats
por: Shabani, Ehsan, et al.
Publicado: (2021)

Comparative application of testosterone undecanoate and/or testosterone propionate in induction of benign prostatic hyperplasia in Wistar rats
por: An, Jinho, et al.
Publicado: (2022)

Benign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of Observational Studies
por: Dai, Xiaoyu, et al.
Publicado: (2016)

Urinary ATP may be a biomarker for bladder outlet obstruction and its severity in patients with benign prostatic hyperplasia
por: Chen, Zhenghao, et al.
Publicado: (2020)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Prostate specific antigen and relative prostate weight data on effect of Tetracarpidium conophorum leaf extract on testosterone-induced benign prostatic hyperplasia
por: Omotosho, Omolola E., et al.
Publicado: (2018)

Rhodobacter sphaeroides Extract Lycogen™ Attenuates Testosterone-Induced Benign Prostate Hyperplasia in Rats
por: Wang, Chiang-Ting, et al.
Publicado: (2018)

Inhibitory effect of curcumin on testosterone induced benign prostatic hyperplasia rat model
por: Kim, Su Kang, et al.
Publicado: (2015)

Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats
por: Al-Trad, Bahaa, et al.
Publicado: (2019)

Inhibitory effects of Ponciri Fructus on testosterone-induced benign prostatic hyperplasia in rats
por: Jeon, Woo-Young, et al.
Publicado: (2017)

Effects of Alginate Oligosaccharide on Testosterone-Induced Benign Prostatic Hyperplasia in Orchiectomized Rats
por: Jang, You-Jee, et al.
Publicado: (2023)

Relationship of Postoperative Recatheterization and Intraoperative Bladder Distention Volume in Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia
por: Kim, Hyeon Jun, et al.
Publicado: (2013)

Modified bladder outlet obstruction index for powerful efficacy prediction of transurethral resection of prostate with benign prostatic hyperplasia
por: Liu, Hongming, et al.
Publicado: (2021)

Comparative RNA-sequencing analysis of the prostate in a mouse model of benign prostatic hyperplasia with bladder outlet obstruction
por: Tang, Xiaohu, et al.
Publicado: (2023)

Treating overactive bladder symptoms after transurethral prostatic surgery for benign prostatic hyperplasia – Which medication to choose?
por: Lee, Cheng-Ling, et al.
Publicado: (2023)

Alterations of gut microbiota diversity, composition and metabonomics in testosterone-induced benign prostatic hyperplasia rats
por: Li, Lu-Yao, et al.
Publicado: (2022)

Effect of Paecilomyces tenuipes Extract on Testosterone-Induced Benign Prostatic Hyperplasia in Sprague–Dawley Rats
por: Choi, Young-Jin, et al.
Publicado: (2019)

Effects of Panax ginseng on the nerve growth factor expression in testosterone induced benign prostatic hyperplasia
por: Kim, Su Kang, et al.
Publicado: (2018)

The fish-hook configuration of the distal ureter indicates bladder outlet obstruction due to benign prostatic hyperplasia
por: Mamoulakis, Charalampos, et al.
Publicado: (2010)

Application of dual-energy spectral CT imaging in differential diagnosis of bladder cancer and benign prostate hyperplasia
por: Chen, Anliang, et al.
Publicado: (2016)

Implication of ultrasound bladder parameters on treatment response in patients with benign prostatic hyperplasia under medical management
por: Thekumpadam Puthenveetil, Rajeev, et al.
Publicado: (2015)

Non-invasive evaluation of bladder outlet obstruction in benign prostatic hyperplasia: a clinical correlation study
por: Reddy, S.V. Krishna, et al.
Publicado: (2019)

Oncological safety of simultaneous transurethral resection of high-grade urothelial carcinoma of the bladder and benign prostatic hyperplasia
por: Sionov, Ben Valery, et al.
Publicado: (2022)

Testosterone therapy: a friend or a foe for the aging men with benign prostatic hyperplasia?
por: Rastrelli, Giulia, et al.
Publicado: (2019)

Importance of prostate volume and urinary flow rate in prediction of bladder outlet obstruction in men with symptomatic benign prostatic hyperplasia
por: Trumbeckas, Darius, et al.
Publicado: (2011)

Benign Prostatic Hyperplasia
Publicado: (2015)

New super-pulse thulium laser for the treatment of benign prostatic hyperplasia and bladder stones: our first experience
por: Persico, Francesco, et al.
Publicado: (2021)

Contemporary Outcomes after Transurethral Procedures for Bladder Neck Contracture Following Endoscopic Treatment of Benign Prostatic Hyperplasia
por: Rosenbaum, Clemens M., et al.
Publicado: (2021)

Genetically supported causality between benign prostate hyperplasia and urinary bladder neoplasms: A mendelian randomization study
por: Du, Wenzhi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hk40goq43m8g08vldqun5uuj35